Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects

Clinical and Experimental Dermatology

Volumn 24, Issue 2, 1999, Pages 112-117

  Jenks, P J ^b   Kavanagh, G M ^b   Brooks, J ^b   Bradfield, J W B ^b   Archer, C B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; CARRIER PROTEIN; HISTAMINE; HUMAN SERUM ALBUMIN; SODIUM CHLORIDE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; ATOPIC DERMATITIS; ATOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXTRAVASATION; FEMALE; HUMAN; HUMAN TISSUE; INTRADERMAL DRUG ADMINISTRATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; SKIN BIOPSY; ULTRASTRUCTURE; URTICARIA; VASCULAR ENDOTHELIUM;

CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HISTAMINE; HUMANS; HYPERSENSITIVITY; MICROSCOPY, ELECTRON; NEUTROPHIL ACTIVATION; NEUTROPHILS; PLATELET ACTIVATING FACTOR; SERUM ALBUMIN; SKIN;

EID: 0032954311     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00429.x     Document Type: Article

References (32)

1. 1 Godfroid JJ, Heymans F, Michel L et al. Platelet activating factor (Paf-acether): total synthesis of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphorylcholine. FEBS Lett 1980; 116: 161.
2. 2 Vargaftig BB, Cignard M, Benveniste J et al. Background and present state of research on platelet activating factor (Paf-acether). Ann NY Acad Sci 1981; 370: 119-37.
3. 3 Czarnetzki BM, Benveniste J. Effect of synthetic Paf-acather on human neutrophil function. Agents Actions 1981; 11: 549-50.
4. 4 Yasaka T, Boxer LA, Baehner RL. Monocyte aggregation and superoxide anion respnse to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet activating factor (PAF). J Immunol 1982; 128; 1939-44.
5. 5 Wardlaw AJ, Magbel R, Cromwell O, Kay AB. Platelet activating factor: a potent chemotactic and chemokinetic factor for human cosinophils. J Clin Invest 1986; 78: 1701-6.
6. 6 Rola Pleszczynski M, Pouliot C, Turiotte S et al. Immune regulation by platelet activating factor. J Imnnmol 1988; 140: 3547-52.
7. 7 Bussolini F, Camussi G, Agbetta M et al. Human endothelial cells are target for platelet activiting factor: (1). Platelet activating factor changes the cytoskeleton structure and promotes albumin diffusion across endothelial monolayers. J Immunol 1987; 139: 2439-46.
8. 8 Humphrey DM, Hanahan DJ. Pinckard RN. Induction of leucocyte infiltrate in rabbit skin by acetyl glyceryl ether phosphorylcholine. Lab Invest 1982; 47: 227-34.
9. 9 Morley J, Page CP, Paul W. Inflammatory actions of platelet activating factor (Paf-acether) in Guinea-pig skin. Br J Pharmacol 1983; 80: 503-9.
10. 10 Dewar A, Archer CB, Paul W et al. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the Guinea-pig. J Pathol 1984; 144: 25-34.
11. 11 Basran GS, Page CP, Paul W, Morley J. Platelet activating factor: a possible mediator of the dual response to allergen. Clin Allergy 1984; 14: 75-9.
12. 12 Archer CB, Page CP, Paul W et al. Inflammatory characteristics of platelet activating factor (Paf-acether) in human skin. Br J Dermatol 1984; 110: 45-50.
13. 13 Archer CB, Page CP, Morley J, MacDonald DM. Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. Br J Dermatol 1985; 112: 285-90.
14. 14 Markey AC, Barker JN, Acher CB et al. Platelet activating factor induced clinical and histopathological responses in atopic skin and their modification by the platelet activating factor antagonist. BN52063. J Am Acad Dermatol 1990; 23: 263-8.
15. 15 Henocq E, Vargaftig BB. Accumulation of cosinophils in response to intracutaneous Paf-acether and allergens in man. Lancet 1986; i: 1378-9.
16. 16 Henocq E, Vargaltig BB. Skin cosinophilia in atopic patients. J Allergy Clin Immunul 1988; 81: 691-5.
17. 17 Coulson I, Holden CA. Cutaneous responses to Substance P and histamine in atopic dermatitis. Br J Dermatol 1990; 122: 343-9.
18. 18 Archer CB, Paul W, Morley J, MacDonald DM. Actions of locally administered adrenoreceptor agonists on histamine induced cutaneous responses in atopic eczema. Clin Exp Dermatol 1984; 9: 358-63.
19. 19 Hoppens CM, Ludwig JC, Castillo R et al. Albumin modification of rabbit platelet activating by 1-O-hexadecyl-2-acctyI-sn-glyceryl-3-phosphorylcholine (AGEPC). Fedn Proc 1983; 42; 693.
20. 20 Archer CB, MacDonald DM, Morley J et al. Effects of serum albumin, indomethacin and histamine HI-antagonist on Paf-acether induced inflammatory responses in the skin of experimental animals and man. Br J Pharmacol 1985; 85: 109-13.
21. 21 Hanifin JM. Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereal (Stockh) 1980; 92 (Suppl.): 44-7.
22. 22 Roberts NM, Page CP, Chung KF, Barnes PJ. Effect of a PAF antagonist BN 52063 on antigen induced acute and late onset cutaneous responses in atopic subjects. J Allergy Clin Immunol 1988; 82: 236-41.
23. 23 Fowler JW, Lovel FC. The accumulation of cosinophils as an allergic response to allergen applied to the denuded skin surface. J Allergy Clin Immunol 1966; 37: 19-28.
24. 24 Ting S, Dunskey El, Lavker RM, Zweiman B. Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions. J Allergy Clin Immunol 1980; 66: 417-21.
25. 25 Lee TC, Lencher DJ, Malone B et al. Increased biosynthesis of platelet activating factor in activated human cosinophils. J Biol Chem 1984; 259: 5526-30.
26. 26 Dorsch W, Ring J, Induction of late cutaneous reactions by skin-blister fluid from allergen tested and normal skin. J Allergy Clin Immunol 1981; 67: 117.
27. 27 Cunningham FM, Leigh I, Mallet AI. The production of platelet activating factor (PAF) by human epidermal cells. Br J Pharmacol 1989; 91: 117P.
28. 28 Michel L, Denizot Y. Thomas Y et al. Biosynthesis of PAF-acather (platelet activating factor-acether) by human skin fibroblasts in vitro. J Immunol 1988; 141: 948-53.
29. 29 Mallet AI, Cunningham FM. Structural identification of platelet activating factor in psoriatic scale. Biochem Biophys Res Commun 1985; 126: 192-8.
30. 30 Grandel KE, Parr RS, Wanderer AA et al. Platelet activating factor in primary acquired cold urticaria. N Engl Med 1985; 313: 405-9.
31. 31 Valone FH, Shalit M, Atkins D et al. Platelet activating factor release in allergic skin sites in humans. J Allergy Clin Immunol 1987; 79: 248.
32. 32 Greaves MW. Pharmacological factors in initiation of cutaneous vasculitis. In: Wolff K, Winkelmann RK, eds. Vasculitis London: Lloyd-Luke (Medical Books) Limited 1980: 49.